Yale Health Professional School Educators Share Medical Education Innovations and Research at Annual Med Ed Day
“How can we uphold and help the Yale System be strong and move forward into the next decade?” Yale School of Medicine (YSM) Deputy Dean for Education, Jessica Illuzzi, MD, MS, professor of Obstetrics, Gynecology and Reproductive Sciences, asked this question during her keynote remarks at the ninth annual Medical Education Day at Yale (Med Ed Day).
Yale Cancer Center Study Shows Immunotherapy Drug Combination Improves Response in HER2-Negative Breast Cancer Including a Subset of Estrogen Receptor Positive Cancers
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.
Yale Cancer Center Study Reveals New Pathway for Brain Tumor Therapy
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.
Yale Cancer Center Study Shows Neuromuscular Dysfunction in Long-term Childhood Cancer Survivors
In a new study led by Yale Cancer Center researchers, neuromuscular dysfunction is found to be prevalent in long-term childhood cancer survivors, continues to increase post-therapy, and is associated with adverse health and socioeconomic outcomes.
Chromosomal Changes in White Blood Cells Increase Risk of Severe Infections
As people age, genetic errors begin to accumulate during the process of cell division. For the study, researchers explored whether one category of these emerging genetic variants in white blood cells — called mosaic chromosomal alterations, or mCAs — played a role in increased infection risk.Source: YaleNews